MIRA
Income statement / Annual
Last year (2025), Mira Pharmaceuticals Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Mira Pharmaceuticals Inc's net income was -$10.44 M.
See Mira Pharmaceuticals Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.72 M
|
$3.31 M
|
$1.57 M
|
$2.35 M
|
$684.45 K
|
$14.65 K
|
| General & Administrative Expenses |
$8.77 M
|
$4.71 M
|
$6.50 M
|
$2.99 M
|
$770.12 K
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.77 M
|
$4.71 M
|
$6.50 M
|
$2.99 M
|
$770.12 K
|
$52.98 K
|
| Other Expenses |
$0.00
|
$0.00
|
$453.55 K
|
$1.70 M
|
$697.60 K
|
$0.00
|
| Operating Expenses |
$10.49 M
|
$8.02 M
|
$8.53 M
|
$7.05 M
|
$2.15 M
|
$67.63 K
|
| Cost And Expenses |
$10.49 M
|
$8.02 M
|
$8.53 M
|
$7.05 M
|
$2.15 M
|
$67.63 K
|
| Interest Income |
$98.91 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$165.67 K
|
$3.46 M
|
$10.25 K
|
$24.37 K
|
$364.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$7.05 M
|
$2.15 M
|
$0.00
|
| EBITDA |
-$10.44 M |
-$8.02 M |
-$8.53 M |
$0.00 |
$0.00 |
-$67.63 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$50.63 K
|
$165.67 K
|
-$3.46 M
|
-$10.25 K
|
-$24.37 K
|
-$364.00
|
| Income Before Tax |
-$10.44 M
|
-$7.85 M
|
-$11.98 M
|
-$7.06 M
|
-$2.18 M
|
-$67.99 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$10.44 M
|
-$7.85 M
|
-$11.98 M
|
-$7.06 M
|
-$2.18 M
|
-$67.99 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.35 |
-0.51 |
-0.65 |
-0.48 |
-0.15 |
-0.0046 |
| EPS Diluted |
-1.35 |
-0.51 |
-0.65 |
-0.48 |
-0.15 |
-0.0046 |
| Weighted Average Shares Out |
$23.69 M
|
$15.44 M
|
$18.57 M
|
$14.75 M
|
$14.75 M
|
$14.75 M
|
| Weighted Average Shares Out Diluted |
$23.69 M
|
$15.44 M
|
$18.57 M
|
$14.75 M
|
$14.75 M
|
$14.75 M
|
| Link |
|
|
|
|
|
|
